Pharmaceutical Technology, Dec 2, 2010 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Dec 2, 2010
Online Exclusives
A Catalyst for Green Synthesis
By Karen E. Holt-Tiffin , Christopher J. Cobley
A new book aims to inspire pharmaceutical chemists.
Special Report
Riding the Employment Roller Coaster
By Michelle Hoffman
2010 came with pay raises for those still employed and anxiety for all. This article contains bonus online material.
The Importance of Equivalence in the Execution and Maintenance of Validation Activities
By James P. Agalloco
The author explains the idea of equivalence and describes how it can facilitate equipment validation.
Technical Note: The Effect of Alcoholic Beverages on Sustained Release
By Anagha Joshi , Shivajirao S. Kadam , Aatmaram P. Pawar
The authors evaluated the effect of alcoholic beverages on the release profiles of sustained-release dosage forms containing metformin and diclofenac.
Ingredients Insider
Advances in Small-Molecule Synthesis
By Patricia Van Arnum
Approaches in cyclization, palladium-catalyzed cross couplings, fluorination, and natural product synthesis help to optimize routes for select drugs.
From The Editor
Quality Issues Redux
By Michelle Hoffman
As we get ready to begin the New Year, let's hope some quality resolutions are made.
PharmTech Talk
Hope for an AIDS Vaccine
By Alexis Pellek
World AIDS Day 2010 reminds us that prevention and hope can help fight the disease.
Agent-in Place
Wasting More Than Time
By Control
Sometimes doing what you think is right ends up being completely and utterly wrong.
Global Healthcare on the Ground: Differential Pricing
By Angie Drakulich
Tiered pricing is used throughout industry to help increase affordability and access to drugs in the developing world.
Report from Asia
By Jane Wan
Global pharmaceutical companies have much to gain in Asia, and the good news is that it's a two-way street. Firms based in Asia are also expected to grow at the global level.
In the Spotlight
In the Spotlight
Editors' picks of pharmaceutical science and technology innovations.
Washington Report
Pharma Faces New Political Landscape
By Jill Wechsler
Republican gains in Congress create uncertainty for healthcare reform, drug regulation, and biomedical research.
Packaging Forum
Packagers for Hire
By Hallie Forcinio
Outsourcing packaging functions can save time and money.
Inside IPEC
Inside IPEC: Global Initiatives to Expand to Latin America
By David R. Schoneker
IPEC extends its reach to Brazil and Argentina in an effort to harmonize excipient best practices.
Outsourcing Outlook
Winning Big
By Jim Miller
Covance's deal with sanofi-aventis demonstrates the power of scale and scope.
Industry Leaders
Q&A with Coldstream CEO Larry Kranking
Larry Kranking, president and CEO of Coldstream Laboratories, discusses industry trends and challenges.
Intellectual Property as the Foundation of Innovation
By James C. Greenwood
Supportive public policy is needed in order for innovation to flourish.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here